Atossa Therapeutics (ATOS) Net Margin (2011 - 2015)
Atossa Therapeutics (ATOS) reported Net Margin of -282229.58% for Q4 2015, down 67964.04 percentage points from -214265.54% a year earlier.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Net Margin (2011 - 2015) Analysis & Trends
For FY2015, Atossa Therapeutics posted Net Margin of -896491.64%, down 859972.81 percentage points from FY2014.
- Net Margin has declined for three consecutive years, with a four-year change of -667007.10 percentage points (FY2011 to FY2015).
- By year, Net Margin came in at -36518.83% in FY2014 (-34813.89 pp), -1704.94% in FY2013 (-650.68 pp), -1054.26% in FY2012 (+228430.28 pp) and -229484.53% in FY2011.
- The Q4 2015 figure ranks as the lowest quarterly Net Margin in data going back to Q4 2011.
- The high point for year-over-year Net Margin in five years was Q4 2012 (a gain of 78627.78 percentage points); the low point was Q4 2014 (a drop of 208424.51 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 19.55% |
| 10 | Atossa Therapeutics | 19.96 Mn | -131.01 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | -282,229.58% |
| Dec 31, 2014 | -214,265.54% |
| Sep 30, 2014 | -94,728.40% |
| Jun 30, 2014 | -32,283.30% |
| Mar 31, 2014 | -9,996.40% |
| Dec 31, 2013 | -5,841.03% |
| Sep 30, 2013 | -4,571.78% |
| Jun 30, 2013 | -792.36% |
| Mar 31, 2013 | -1,062.81% |
| Dec 31, 2012 | -1,732.35% |
| Sep 30, 2012 | -1,082.99% |
| Jun 30, 2012 | -523.52% |
| Mar 31, 2012 | -1,942.71% |
| Dec 31, 2011 | -80,360.13% |
API Access
Atossa Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();